IHS Markit (NASDAQ:INFO) Updates FY 2019 Earnings Guidance

IHS Markit (NASDAQ:INFO) issued an update on its FY 2019 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.52-2.57 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.55. The company issued revenue guidance of $4.425-4.5 billion, compared to the consensus revenue estimate of $4.45 billion.IHS Markit also updated its FY19 guidance to $2.52-2.57 EPS.

IHS Markit stock traded up $0.16 during trading hours on Thursday, reaching $65.53. 1,296,740 shares of the company’s stock were exchanged, compared to its average volume of 1,800,440. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.66 and a quick ratio of 0.66. The stock’s 50 day moving average price is $61.63. IHS Markit has a twelve month low of $44.52 and a twelve month high of $65.82. The firm has a market cap of $26.22 billion, a price-to-earnings ratio of 33.10, a PEG ratio of 2.83 and a beta of 0.82.

IHS Markit (NASDAQ:INFO) last issued its quarterly earnings results on Wednesday, June 26th. The business services provider reported $0.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.06. The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.14 billion. IHS Markit had a return on equity of 10.13% and a net margin of 10.49%. The business’s revenue was up 12.6% compared to the same quarter last year. During the same period last year, the business posted $0.61 EPS. On average, research analysts expect that IHS Markit will post 2.13 EPS for the current fiscal year.

Several analysts have recently commented on INFO shares. Morgan Stanley raised their target price on Ollie’s Bargain Outlet from $74.00 to $79.00 and gave the company an equal weight rating in a research note on Wednesday, March 27th. Zacks Investment Research downgraded IQIYI from a hold rating to a sell rating in a research note on Friday, March 29th. Deutsche Bank set a $142.00 price target on MCCORMICK & CO /SH and gave the company a hold rating in a research note on Friday, June 28th. Cantor Fitzgerald cut shares of Arrowhead Pharmaceuticals from an overweight rating to a neutral rating and set a $24.00 target price on the stock. in a research report on Thursday, June 27th. Finally, SunTrust Banks dropped their target price on shares of Focus Financial Partners and set a hold rating on the stock in a research report on Thursday, June 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of $61.85.

In other news, CEO Lance Darrell Gordon Uggla sold 30,000 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $54.50, for a total value of $1,635,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Adam Jason Kansler sold 50,000 shares of the stock in a transaction on Friday, July 12th. The stock was sold at an average price of $65.53, for a total value of $3,276,500.00. Following the completion of the transaction, the executive vice president now directly owns 169,467 shares of the company’s stock, valued at approximately $11,105,172.51. The disclosure for this sale can be found here. Insiders have sold 345,000 shares of company stock valued at $21,701,600 over the last ninety days. 1.11% of the stock is currently owned by corporate insiders.

About IHS Markit

IHS Markit Ltd. provides critical information, analytics, and solutions for various industries and markets that drive economies worldwide. The company's information, analytics, and solutions enhance operational efficiency and offer deep insights for customers in business, finance, and government.

Recommended Story: Fundamental Analysis and Choosing Stocks

Earnings History and Estimates for IHS Markit (NASDAQ:INFO)

Receive News & Ratings for IHS Markit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IHS Markit and related companies with MarketBeat.com's FREE daily email newsletter.